<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/704465FD-27ED-43B4-955C-89C9CEB0C57A" ns1:id="704465FD-27ED-43B4-955C-89C9CEB0C57A"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/6DB8888B-C240-4470-9724-E471AD47A33F" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/2BD0EA2C-8F60-47E3-926A-1751D471682A" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/3D826409-4B9A-4FB8-AA5E-96FC9C987CC9" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/2BD0EA2C-8F60-47E3-926A-1751D471682A" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2024-04-29T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/A54DEB93-793A-41CD-AA8D-CD0B1E461A7D" ns1:rel="FUND" ns1:start="2022-09-30T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">10035475</ns2:identifier></ns2:identifiers><ns2:title>The development of a novel inkjet bioprinter and software operating system, enabling high precision next generation 3D bioprinting.</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>High precision inkjet bioprinting has the potential to improve critical biomedical research, whilst replacing/reducing reliance on animal testing. Currently, the precision of bioprinting platforms for the research sector is limited and incapable of recreating complex architectures visualised _in vivo_ efficiently, with batch-to-batch consistency, for a tissue of interest, This project will see the development of a novel inkjet bioprinting system with a bespoke software operating system, as well as a next generation inkjet collagen Type 0 bioink formulation derived from jellyfish offering the ability to recreate complex 3D architecture and optimal in vivo efficacy.</ns2:abstractText></ns2:project>